CompletedNot Applicable

Evaluating the Effectiveness of Piscean Derived Collagen Dressing on Neuropathic Diabetic Foot Ulcer in T2DM Patients

Pakistan180 participantsStarted 2021-12-02

Plain-language summary

Diabetic foot ulcers (DFU) are challenging to treat with complicated healing processes and require advanced wound care. Piscean collagen has the potential to promote the regenerative process while remaining cost-effective and with minimal side effects. In this study, the efficacy of a piscean collagen matrix dressing was compared with a standard dressing of saline-moistened gauze for wound healing in patients with neuropathic DFU. This is a double-blinded, randomised clinical trial.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with neuropathic DFUs at Grades I or II for a period of at least 12 weeks, based on the Wagner classification; * be able to understand simple instructions and provided voluntary, signed informed consent. Exclusion Criteria: * active infection which might lead to hospitalisation, gangrene, * systemic inflammatory or autoimmune disease * renal failure * presence of ischaemia or osteomyelitis

What they're measuring

Change in DFU size

Timeframe: 3 months

Trial details

NCT IDNCT05324930

SponsorCorporacion Parc Tauli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Diabetic Foot Ulcer Neuropathic trials